Menopause is a female physiological process involving the permanent cessation of menstruation and reproductive function as a result of ovarian failure. It occurs at approximately 51 years of age, resulting in broad and diverse metabolic, psychological, and urogenital consequences, often leading to poor quality of life. Hormone changes present in menopause, especially the decrease in serum estrogen levels, positively correlate with the development of obesity and mood disorders, such as depression and anxiety. Taking into consideration the elevated risks involved in both obesity-related metabolic disorders and psychological disorders it is extremely important to understand the physiological phenomena involved in this process. In addition, considering that women are expected to spend at least one-third of their lives after menopause, the development of new pharmacological approaches focusing on the attenuation of menopause-related complications, especially overweight/obesity and mood disorders is highly necessary.
This Research Topic will provide a comprehensive overview on the physiology of menopause, menopause-related complications, and new pharmacological approaches. We welcome the submission of review, mini-review, and original research articles covering, but not limited to, the following topics:
• Menopause and ovarian function
• Menopause-related metabolic disorders
• Menopause-related psychological disorders
• New pharmacological approaches to treat menopause-related disorders
• The use of bioactive compounds to treat menopause-related disorders
• Hormone replacement therapy
Menopause is a female physiological process involving the permanent cessation of menstruation and reproductive function as a result of ovarian failure. It occurs at approximately 51 years of age, resulting in broad and diverse metabolic, psychological, and urogenital consequences, often leading to poor quality of life. Hormone changes present in menopause, especially the decrease in serum estrogen levels, positively correlate with the development of obesity and mood disorders, such as depression and anxiety. Taking into consideration the elevated risks involved in both obesity-related metabolic disorders and psychological disorders it is extremely important to understand the physiological phenomena involved in this process. In addition, considering that women are expected to spend at least one-third of their lives after menopause, the development of new pharmacological approaches focusing on the attenuation of menopause-related complications, especially overweight/obesity and mood disorders is highly necessary.
This Research Topic will provide a comprehensive overview on the physiology of menopause, menopause-related complications, and new pharmacological approaches. We welcome the submission of review, mini-review, and original research articles covering, but not limited to, the following topics:
• Menopause and ovarian function
• Menopause-related metabolic disorders
• Menopause-related psychological disorders
• New pharmacological approaches to treat menopause-related disorders
• The use of bioactive compounds to treat menopause-related disorders
• Hormone replacement therapy
